Recap: MiNK Therapeutics Q1 Earnings

Comments
Loading...

MiNK Therapeutics INKT reported its Q1 earnings results on Thursday, May 11, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

MiNK Therapeutics beat estimated earnings by 29.17%, reporting an EPS of $-0.17 versus an estimate of $-0.24.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 2.37% increase in the share price the next day.

To track all earnings releases for MiNK Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

INKT Logo
INKTMiNK Therapeutics Inc
$8.6112.4%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum99.82
Growth-
Quality-
Value-
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: